Dualyx NV

BiotechnologySeries AGhent, Belgiumdualyx.com

Latest round

Series A

Last raised

May 2023

Total raised

$35M

Investors

10

About Dualyx NV

Based in Zwijnaarde, Belgium, and founded in 2020 by CSO Luc van Rompaey with Wurzburg University, Argenx, VIB, Ghent University, and KU Leuven, Dualyx NV operates as a biotechnology company providing Treg-based therapies to support the patients with difficult-to-treat autoimmune diseases.U. Dualyx NV developed immune modulators for identifying the in vivo expansion of regulatory T cells. The company’s technology allows users to improve and activate potent Treg cells can restore the ratio of regulatory to effector T cells and suppress the unwanted autoimmune reaction to achieve long-lasting or even curative treatments in autoimmune disease patients. In addition, the firm provides DT-001 which is a program for modulating the validated immune suppression target TNF receptor 2.

Who invested in Dualyx NV

10 investors across 2 rounds

See all investors in Dualyx NV

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    May 8, 2023

    Amount

    $28M

    Investors

    Locked

  2. Seed

    Apr 10, 2020

    Amount

    $7.7M

    Investors

    Locked

Questions about Dualyx NV

Who invested in Dualyx NV?

Dualyx NV has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Dualyx NV raised?

Dualyx NV has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Dualyx NV last raise money?

Dualyx NV's most recent round on record is a Series A, in May 2023.

What does Dualyx NV do?

Based in Zwijnaarde, Belgium, and founded in 2020 by CSO Luc van Rompaey with Wurzburg University, Argenx, VIB, Ghent University, and KU Leuven, Dualyx NV operates as a biotechnology company providing Treg-based therapies to support the patients with difficult-to-treat autoimmune diseases.

Where is Dualyx NV headquartered?

Dualyx NV is headquartered in Ghent, Belgium.

Which VCs invest in companies like Dualyx NV?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Dualyx NV's stage. Their profiles are linked below.

Raising like Dualyx NV? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.